Home » Topics » BioWorld Science

BioWorld Science
RSS

Preclinical evaluation of novel nonimmunogenic utrophin gene therapy for DMD

Oct. 17, 2019

Positive biomarker results presented from phase I study of XCUR-17

Oct. 17, 2019

Further clinical data presented from phase I/II bladder cancer study of Alpha1H

Oct. 17, 2019

First patient enrolled in phase II study of novel cystic fibrosis treatment, BI-1265162

Oct. 17, 2019

Hepagene begins phase I trial of FXR agonist HPG-1860 for NASH

Oct. 17, 2019

Enterprise Therapeutics receives funding for development of novel CF therapy

Oct. 17, 2019

Milasen, individualized gene therapy for rare genetic disease

Oct. 17, 2019

P63 is behind thalidomide birth defects

Oct. 17, 2019

Anticoagulants prevent AD symptoms

Oct. 17, 2019

Phase III SEQUOIA study of pegilodecakin in metastatic pancreatic cancer misses primary endpoint

Oct. 16, 2019

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...